![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
SA Grevelink, J Osborne, J Loscalzo and EA Lerner
Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown.
Maxadilan is a potent vasodilator isolated from salivary gland extracts of the sand fly. Although cutaneous vasodilatation is probably the most important physiologic effect of maxadilan (i.e., assisting the sand fly in obtaining a blood meal), it also has effects on other vascular beds. In rabbit isolated aorta, recombinant maxadilan exhibited endothelium- independent relaxations with an IC50 of 24 nM for norepinephrine- induced (1 microM) contractions. Synthetic maxadilan had one-third the potency, with a corresponding IC50 of 74 nM for norepinephrine-induced (1 microM) contractions. Pretreatment with a number of receptor and channel blockers, including tetraethylammonium (1 mM), glyburide (1 microM), barium (0.5 mM), indomethacin (10 microM), propranolol (10 microM), cimetidine (10 microM) and nifedipine (10 microM) did not affect maxadilan-induced relaxations. After treatment with maxadilan, contractions recurred very slowly over approximately 40 min. At a concentration of 1 microM, maxadilan induced a 2- to 3-fold increase in cellular cyclic AMP levels. Maxadilan's activity was selective according to vessel type, with maximal activity in rabbit aorta and mesenteric artery and no activity in porcine and bovine coronary arteries. These studies suggest that maxadilan acts by raising the intracellular levels of cyclic AMP in the smooth muscle of selected blood vessels.
This article has been cited by other articles:
|
|
 |
|
  P. Takac, M. A. Nunn, J. Meszaros, O. Pechanova, N. Vrbjar, P. Vlasakova, M. Kozanek, M. Kazimirova, G. Hart, P. A. Nuttall, et al. Vasotab, a vasoactive peptide from horse fly Hybomitra bimaculata (Diptera, Tabanidae) salivary glands J. Exp. Biol., January 15, 2006; 209(2): 343 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. B. Norsworthy, J. Sun, D. Elnaiem, G. Lanzaro, and L. Soong Sand Fly Saliva Enhances Leishmania amazonensis Infection by Modulating Interleukin-10 Production Infect. Immun., March 1, 2004; 72(3): 1240 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. MILLERON, J. M. C. RIBEIRO, D. ELNAIME, L. SOONG, and G. C. LANZARO NEGATIVE EFFECT OF ANTIBODIES AGAINST MAXADILAN ON THE FITNESS OF THE SAND FLY VECTOR OF AMERICAN VISCERAL LEISHMANIASIS Am J Trop Med Hyg, March 1, 2004; 70(3): 278 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. P. Soares, R. G. Titus, C. B. Shoemaker, J. R. David, and M. Bozza The Vasoactive Peptide Maxadilan from Sand Fly Saliva Inhibits TNF-{alpha} and Induces IL-6 by Mouse Macrophages Through Interaction with the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Receptor J. Immunol., February 15, 1998; 160(4): 1811 - 1816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Moro and E. A. Lerner Maxadilan, the Vasodilator from Sand Flies, Is a Specific Pituitary Adenylate Cyclase Activating Peptide Type I Receptor Agonist J. Biol. Chem., January 10, 1997; 272(2): 966 - 970. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
